PL374855A1 - Nowa amorficzna 9-deokso-9a-aza-9a-metylo-9a-homoerytromycyna A, sposób jej wytwarzania i zastosowanie - Google Patents

Nowa amorficzna 9-deokso-9a-aza-9a-metylo-9a-homoerytromycyna A, sposób jej wytwarzania i zastosowanie

Info

Publication number
PL374855A1
PL374855A1 PL03374855A PL37485503A PL374855A1 PL 374855 A1 PL374855 A1 PL 374855A1 PL 03374855 A PL03374855 A PL 03374855A PL 37485503 A PL37485503 A PL 37485503A PL 374855 A1 PL374855 A1 PL 374855A1
Authority
PL
Poland
Prior art keywords
homoerythromycin
deoxo
aza
methyl
preparing
Prior art date
Application number
PL03374855A
Other languages
English (en)
Inventor
Miljenko Dumic
Mladen Vinkovic
Marina Oresic
Ernest Mestrovic
Aleksandar Danilovski
Alojz Dumbovic
Zdravka Knezevic
Gorjana Lazarevski
Darko Filic
Dominik Cincic
Katica Lazaric
Dejan-Kresimir Bucar
Original Assignee
Pliva-Istrazivanje I Razvoj D.O.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva-Istrazivanje I Razvoj D.O.O. filed Critical Pliva-Istrazivanje I Razvoj D.O.O.
Publication of PL374855A1 publication Critical patent/PL374855A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PL03374855A 2002-07-22 2003-07-21 Nowa amorficzna 9-deokso-9a-aza-9a-metylo-9a-homoerytromycyna A, sposób jej wytwarzania i zastosowanie PL374855A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HR20020614A HRP20020614A2 (en) 2002-07-22 2002-07-22 Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a

Publications (1)

Publication Number Publication Date
PL374855A1 true PL374855A1 (pl) 2005-11-14

Family

ID=30471419

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03374855A PL374855A1 (pl) 2002-07-22 2003-07-21 Nowa amorficzna 9-deokso-9a-aza-9a-metylo-9a-homoerytromycyna A, sposób jej wytwarzania i zastosowanie

Country Status (9)

Country Link
US (1) US6936591B2 (pl)
EP (1) EP1551854A2 (pl)
JP (1) JP2006501197A (pl)
CN (1) CN1671725A (pl)
AR (1) AR040652A1 (pl)
AU (1) AU2003253010A1 (pl)
HR (1) HRP20020614A2 (pl)
PL (1) PL374855A1 (pl)
WO (1) WO2004009608A2 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2600577T3 (es) 2003-12-04 2017-02-09 Bend Research, Inc. Procedimiento de pulverización-solidificación que usa un extrusor para preparar composiciones en multipartículas de fármacos cristalinos
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7906137B2 (en) * 2004-05-21 2011-03-15 Mediplex Corporation, Korea Delivery agents for enhancing mucosal absorption of therapeutic agents
US20090318375A1 (en) * 2005-06-08 2009-12-24 Hanmi Pharm Co., Ltd Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same
JP2009501206A (ja) * 2005-07-14 2009-01-15 ファイザー・プロダクツ・インク 非晶質アジスロマイシン粒子の生成方法
US20100021538A1 (en) * 2008-02-29 2010-01-28 Youngro Byun Pharmaceutical compositions containing heparin derivatives
CA2784494C (en) * 2009-12-18 2019-03-12 North-West University Composition comprising an amorphous non-crystalline glass form of roxithromycin
WO2013088274A1 (en) * 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
US9951009B2 (en) * 2013-08-29 2018-04-24 Cadila Healthcare Limited Polymorphic form of pyrrole derivative and intermediate thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
WO1989000576A1 (en) 1987-07-09 1989-01-26 Pfizer Inc. Azithromycin dihydrate
HRP20020231A2 (en) 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
US5686587A (en) * 1993-05-19 1997-11-11 Pfizer Inc. Intermediate for azithromycin
CA2163837C (en) * 1994-12-13 1999-07-20 Robert K. Perrone Crystalline paclitaxel hydrates
ES2122905B1 (es) * 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
TW546302B (en) 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
CA2245398C (en) * 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
SI20639A (sl) * 1998-11-30 2002-02-28 Teva Pharmaceutical Industries Ltd. Etanolat azitromicina, postopek za njegovo pripravo in njegovi farmacevtski sestavki
AU5820400A (en) * 1999-06-29 2001-01-31 Biochemie S.A. Macrolides
ES2177373B1 (es) 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina
EP1246831B1 (en) 2000-01-04 2008-03-05 Teva Pharmaceutical Industries Ltd. Preparation method of azithromycin dihydrate
ES2162764B1 (es) 2000-05-17 2003-04-01 Ercros Ind Sa Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion.
DE60026718T2 (de) 2000-07-25 2006-11-16 Laboratorio Silanes, S.A. De C.V. Einstufiges verfahren zur herstellung von 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle(11.2.11)hexadeca-1(2)-en-8-ona undeine neue form von 9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a
WO2002009640A2 (en) 2000-08-01 2002-02-07 Shiva Prasad Singh Process for the preparation of anhydrous azithromycin
JP2004506664A (ja) 2000-08-23 2004-03-04 ウォックハート・リミテッド 無水アジトロマイシンの製造法
HRP20030430B1 (hr) 2000-11-27 2011-11-30 Biochemie S.A. Makrolidni solvati
KR100491183B1 (ko) 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
KR100431431B1 (ko) 2001-04-25 2004-05-14 한미약품 주식회사 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
HRP20010301A2 (en) 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
ES2258142T3 (es) * 2001-05-22 2006-08-16 Pfizer Products Inc. Nueva forma cristalina.
PL371259A1 (pl) * 2001-12-21 2005-06-13 Pfizer Products Inc. Bezpośrednio sprasowywalne preparaty azytromycyny
NZ532063A (en) * 2001-12-21 2006-03-31 Pfizer Prod Inc Methods for wet granulating azithromycin
RU2283092C2 (ru) 2002-02-01 2006-09-10 Пфайзер Продактс Инк. Сухие гранулированные композиции азитромицина
BRPI0311176B8 (pt) * 2002-05-16 2021-05-25 Janssen Sciences Ireland Uc pseudopolimorfo na forma de etanolato, seu uso, processo de preparação do mesmo e composição farmacêutica
ITMI20021209A1 (it) 2002-06-04 2003-12-04 Chemi Spa Processo di preparazione di azitromicina ad elevata purezza

Also Published As

Publication number Publication date
US20040092460A1 (en) 2004-05-13
AU2003253010A8 (en) 2004-02-09
AR040652A1 (es) 2005-04-13
HRP20020614A2 (en) 2004-06-30
JP2006501197A (ja) 2006-01-12
CN1671725A (zh) 2005-09-21
AU2003253010A1 (en) 2004-02-09
WO2004009608A2 (en) 2004-01-29
US6936591B2 (en) 2005-08-30
WO2004009608A3 (en) 2004-03-25
EP1551854A2 (en) 2005-07-13

Similar Documents

Publication Publication Date Title
TWI315741B (en) A-isomaltosyltransferase, process for producing the same and use thereof
PL351148A1 (en) 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
HUP0401293A3 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
TWI346574B (en) A catalyst composition, a process for preparing the catalyst composition and a use of the catalyst composition
TWI319764B (en) Mercaptoacetylamide derivatives, a process for their preparation and their use
AU2003266194A8 (en) Nanocomposite, method for production and use thereof
TWI318135B (en) A process for preparing a catalyst, the catalyst and a use of the catalyst
AU2002353096A1 (en) Process for preparing a k-type polarizer
AU2003254864A1 (en) Novel triarylamine polymer, process for producing the same, and use thereof
AU2003232894A8 (en) Amorphous diamond materials and associated methods for the use and manufacture thereof
AU2003253010A8 (en) Novel amorphous 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a, process for preparing the same, and use thereof
EP1550862A4 (en) PLATE FOR MASS SPECTROMETRY, PROCESS FOR PREPARING THE SAME, AND USE OF SAID PLATE
ZA200500526B (en) Prodrug, medicinal utilization thereof and process for producing the same
GB0201505D0 (en) Process
AU2003289176A1 (en) 1,3-benzothiazinone derivatives, process for producing the same and use thereof
AU2003236090A1 (en) Allochroic fiber desiccant, process for preparing the same and use
GB0202564D0 (en) Process
GB0201378D0 (en) Process
AU2003201857A1 (en) Bisphosphine, process for producing the same, and use thereof
IL150907A0 (en) Stable amorphous calcium pseudomonate and process for the preparation thereof
IL175408A0 (en) A soil-fumigant-containing material and a process for the preparation thereof
AU2003235121A1 (en) Novel thiol derivative, process for producing the same and use thereof
GB0202563D0 (en) Process
AU2003266528A1 (en) Cyclic amine compound, process for producing the same, and use
AU2003250069A1 (en) Polymethylene amine, method for the production and use thereof

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)